• CD28 targeting
  • How it works

Pipeline

Bispecific antibody programs

Bispecific antibody programs

Multispecific antibody programs

Monoclonal antibody programs

Monoclonal antibody programs

Multispecific antibody programs

Back

New publication in ImmunoTherapy of Cancer

Selective activation of interleukin-2/interleukin-15 receptor signaling in tumor microenvironment using paired bispecific antibodies

Read more

LinkedIn